Bayesian Capital Management’s Select Medical SEM Stock Holding History

Bayesian Capital Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,779	Closed	-$314K	–	513
2021 Q2	$314K	Sell	13,779 -6,767	-33%	-$140K	0.08%	268
2021 Q1	$377K	Buy	+20,546	New	+$337K	0.09%	298
2020 Q3	–	Sell	-23,571	Closed	-$187K	–	672
2020 Q2	$187K	Sell	23,571 -15,591	-40%	-$129K	0.04%	442
2020 Q1	$316K	Buy	+39,162	New	+$465K	0.07%	436
2019 Q2	–	Sell	-22,515	Closed	-$171K	–	661
2019 Q1	$171K	Buy	+22,515	New	+$181K	0.03%	489
2017 Q4	–	Sell	-31,691	Closed	-$328K	–	702
2017 Q3	$328K	Buy	31,691 +12,760	+67%	+$118K	0.08%	344
2017 Q2	$157K	Sell	18,931 -20,411	-52%	-$153K	0.06%	383
2017 Q1	$283K	Buy	+39,342	New	+$285K	0.13%	266
2016 Q2	–	Sell	-36,509	Closed	-$232K	–	531
2016 Q1	$232K	Buy	+36,509	New	+$196K	0.22%	237

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bayesian Capital Management's SEM Position: Q3 2021 in Review

Bayesian Capital Management sold out of Select Medical (SEM) in Q3 2021, closing a stake of 13,779 shares — an estimated $314K sold.

Bayesian Capital Management first reported a position in SEM in Q1 2016 and held it in 9 quarters. The position peaked at $377K in Q1 2021. 252 funds tracked by Wall St. Rank hold SEM as of Q3 2021.

Bayesian Capital Management reported no remaining Select Medical position as of Q3 2021 after selling out during the quarter.
Bayesian Capital Management sold 13,779 Select Medical shares in Q3 2021, an estimated $314K.
Bayesian Capital Management first reported a position in Select Medical in Q1 2016 and held it in 9 quarters.
Bayesian Capital Management's Select Medical position peaked at $377K in Q1 2021.
252 funds tracked by Wall St. Rank held Select Medical as of Q3 2021.

Based on Bayesian Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.